Fig. 5From: Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trialsOverall analysis of denosumab versus ZA. Forest plots of incidence of AE (A), serious AEs (B), and renal toxicity (C)Back to article page